Kwangdong Healthbio Co., Ltd. (XKON:086220)
South Korea · Delayed Price · Currency is KRW 1,340.00
-39.00 (-2.83%)
At close: Feb 2, 2026
Kwangdong Healthbio Revenue
In the year 2014, Kwangdong Healthbio had annual revenue of 38.10B KRW with 19.85% growth.
Revenue
38.10B
Revenue Growth
-2.50%
P/S Ratio
0.45
Revenue / Employee
470.33M
Employees
81
Market Cap
17.00B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2014 | 38.10B | 6.31B | 19.85% |
| Dec 31, 2013 | 31.79B | -4.07B | -11.35% |
| Dec 31, 2012 | 35.86B | 6.04B | 20.27% |
| Dec 31, 2011 | 29.81B | -17.09B | -36.44% |
| Dec 31, 2010 | 46.91B | 527.66M | 1.14% |
| Dec 31, 2009 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2008 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2007 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2006 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2005 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Hurum | 95.37B |
| ChoA Pharmaceutical Co., LTD. | 60.50B |
| CXI Healthcare Technology Group | 55.74B |
| WooGene B&G | 54.77B |
| Seoul Pharma | 52.43B |
| Union Korea Pharm | 33.83B |
| Daesung Microbiological Labs. | 25.86B |
| BIFIDO | 18.65B |